Abstract | OBJECTIVE: This article reviews information on the role of three antileukotrienes (anti-LTs), montelukast, zafirlukast, and zileuton, in the management of asthma. After reading this article, readers should have an understanding of the efficacy of anti-LTs in specific patient populations. DATA SOURCES: Relevant and appropriately controlled clinical studies on the efficacy of anti-LTs were used. Only literature in the English language was reviewed. STUDY SELECTION: Material was taken from peer-reviewed journals and published abstracts. RESULTS: The efficacy of anti-LTs has been established in numerous randomized, controlled, multicenter trials involving patients with mild-to-moderate disease. These agents reduce asthma symptoms, beta2-agonist use, and asthma exacerbations, in addition to improving pulmonary function. The anti-LTs are also effective when added to low-dose or high-dose corticosteroid regimens in symptomatic asthma patients. They have proven efficacy in patients with aspirin-sensitive asthma, and they appear able to reduce nasal congestion in asthma patients with concomitant upper airway symptoms. Some anti-LTs have been shown to be effective in pediatric asthma patients. CONCLUSIONS: In reviewing available clinical results as well as real-world experience in managing asthma patients, the Antileukotriene Working Group concludes that anti-LTs may be used in patients with mild persistent asthma as well as in combination with other asthma medications at all levels of disease severity for long-term maintenance of asthma control.
|
Authors | R A Nathan, J P Kemp, Antileukotriene Working Group |
Journal | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
(Ann Allergy Asthma Immunol)
Vol. 86
Issue 6 Suppl 1
Pg. 9-17
(Jun 2001)
ISSN: 1081-1206 [Print] United States |
PMID | 11426917
(Publication Type: Journal Article, Review)
|
Chemical References |
- Adrenal Cortex Hormones
- Anti-Asthmatic Agents
- Leukotriene Antagonists
|
Topics |
- Adrenal Cortex Hormones
(therapeutic use)
- Anti-Asthmatic Agents
(therapeutic use)
- Asthma
(drug therapy)
- Clinical Trials as Topic
- Humans
- Leukotriene Antagonists
(therapeutic use)
|